Bioresorbable drug eluting intravitreal implant system and method

摘要

A bioresorbable drug eluting intravitreal implant system includes a syringe with a chamber containing a medicinal drug. A balloon is releasably secured to a needle where the needle has a central section chamber in fluid communication with a chamber in the syringe. The needle central section has an opening formed through a wall for transporting the medicinal drug to the interior of the balloon subsequent to insertion of the needle through the sclera of a patient's eye.

主权项

1. A method of implanting a bioresorbable drug into an eye of a patient including the steps of:
(a) establishing a balloon shaped member having a proximal end and a distal end, said balloon shaped member having a through opening extending from said proximal end to said distal end thereof, wherein said balloon shaped member has an unexpanded configuration and an expanded configuration; (b) establishing a needle member with a closed distal section, a proximal section, and a central section therebetween, forming a central section chamber defined by walls of said needle member at said central section thereof, and forming at least one opening through said walls of said needle member at said central section thereof, wherein said central section chamber has a distal wall positioned in proximity to said distal section of said needle member to block a fluid communication between said central section chamber and said distal section of said needle member, releasably mounting said balloon shaped member, in its unexpanded configuration, in alignment with said at least one opening, over said needle member with said distal and proximal ends of said balloon shaped member in releasable contact with said closed distal section and said proximal section of said needle member, respectively; (c) inserting said needle member, carrying said balloon shaped member in said unexpanded configuration, through the sclera of the patient's eye to a predetermined depth; (d) subsequently to inserting said needle member to a desired location in the patient's eye, inflating said balloon shaped member with a medicinal drug transported from said central section chamber formed in said needle central section to an interior of said balloon shaped member through said at least one opening formed through the walls of said central section of said needle member; (e) subsequently to inflating said balloon member with said medicinal drug, withdrawing the needle member from the expanded balloon member and from interior of the patient's eye; and (f) maintaining said expanded balloon shaped member within the patient's eye.